| Name | LHC-165 |
|---|
| Description | LHC-165 is a TLR7 agonist. Has potential to treat solid tumors[1][2]. |
|---|---|
| Related Catalog | |
| Target |
TLR7 |
| References |
[2]. LHC165. |
| Molecular Formula | C29H32F2N3O7P |
|---|---|
| Molecular Weight | 603.55 |